The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2024

Filed:

Aug. 04, 2021
Applicant:

Ablevia Biotech Gmbh, Vienna, AT;

Inventors:

Oskar Smrzka, Vienna, AT;

Bettina Wanko, Vienna, AT;

Assignee:

ABLEVIA BIOTECH GMBH, Vienna, AT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 38/00 (2006.01); A61K 47/64 (2017.01); C07K 5/04 (2006.01); C07K 7/06 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6811 (2017.08); A61K 47/643 (2017.08); A61K 47/644 (2017.08); C07K 5/04 (2013.01); C07K 7/06 (2013.01); A61K 38/00 (2013.01); C07K 16/18 (2013.01);
Abstract

The present invention provides a compound for the sequestration of undesirable antibodies (e.g. related to an autoimmune disease) in a patient. The compound comprises an inert biopolymer scaffold and at least a first peptide n-mer of the general formula P(—S—P)and a second peptide n-mer of the general formula P(—S—P); wherein, independently for each occurrence, P is a peptide with a sequence length of 2-13 amino acids and S is a non-peptide spacer, wherein, independently for each of the peptide n-mers, n is an integer of at least 1, wherein each of the peptide n-mers is bound to the biopolymer scaffold. Also provided are pharmaceutical compositions comprising the compound, as well as a method of sequestering one or more antibodies present in an individual and a method of inhibiting an immune reaction to a treatment with an active agent.


Find Patent Forward Citations

Loading…